Powderous formulations of organic acids or esters having an aromatic ring system

US9693938B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9693938-B2
Application numberUS-201414907656-A
CountryUS
Kind codeB2
Filing dateJul 25, 2014
Priority dateJul 26, 2013
Publication dateJul 4, 2017
Grant dateJul 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to improved powderous formulations comprising a high amount of at least one organic acids or esters having an aromatic ring system, as well as to the production of such formulations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A powderous formulation comprising (i) 70-95 wt %, based on the total weight of the powderous formulation, of at least one compound of formula (I):  wherein X is —N— or —CH—, and R 1 is H or a C 1 -C 4 alkyl moiety, and (ii) 10-30 wt %, based on the total weight of the powderous formulation, of at least one auxiliary compound selected from the group consisting of ammonium dihydrogen phosphate, purified diatomaceous earth, potassium hydrogen carbonate, potassium sulphate, potassium carbonate, sodium chloride and sodium hydrogen carbonate, wherein the powderous formulation has minimum ignition energy (MIE) value of 10 mJ or greater. 2. The powderous formulation according to claim 1 , wherein the at least one compound of formula (I) is at least one compound of formula (Ia) and (Ib): 3. The powderous formulation according to claim 1 , wherein the auxiliary compounds have an average particle size (d 0.5) in the powder formulation of 10 μm-100 μm. 4. The powderous formulation according to claim 1 , wherein the compounds of formula (I) is present in an amount sufficient to impart a MIE value to the formulation of 10-1000 mJ. 5. The powderous formulation according to claim 1 , wherein the compounds of formula (I) is present in an amount sufficient to impart a MIE value to the formulation of more than 1000 mJ. 6. The powderous formulation according to claim 1 , comprising 0-5 wt-%, based on the total weight of the formulation, of water. 7. A powderous formulation according to claim 1 , wherein the formulation further comprises: (iii) up to 40 wt-%, based on the total weight of the formulation, of at least one carrier material selected from the group consisting of synthetically produced precipitated silicas, formiates, proteins, starches, lignosulfonates and gums. 8. A powderous formulation consisting of: (i) 70-90 wt-%, based on the total weight of the powderous formulation, of at least one compound of formula (Ia) and (Ib):  and (ii) 10-30 wt-%, based on the total weight of the powderous formulation, of at least one auxiliary compound selected from the group consisting of ammonium dihydrogen phosphate, diatomaceous earth, potassium hydrogen carbonate, potassium sulphate, potassium carbonate, sodium chloride, sodium sulphate and sodium hydrogen carbonate, and (iii) 0-5 wt-%, based on the total weight of the powderous formulation, of water, wherein the powderous formulation has a minimum ignition energy (MIE) value of 10 mJ or greater. 9. A food product, feed product or personal care product comprising the powderous formulation according to claim 1 .

Assignees

Inventors

Classifications

  • Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)} · CPC title

  • Carboxylic acids; Salts or anhydrides thereof · CPC title

  • Containing particulates characterized by their shape and/or structure (see also A61K8/04, A61K8/11, and A61K8/14, further aspects are classified in A61K2800/40 and subcodes) · CPC title

  • free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added (A23P10/20, A23P10/30 take precedence) · CPC title

  • Vitamins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9693938B2 cover?
The present invention relates to improved powderous formulations comprising a high amount of at least one organic acids or esters having an aromatic ring system, as well as to the production of such formulations.
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification A61K8/25. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).